Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Glycophos (sodium glycerophosphate)FDA approves Glycophos (sodium glycerophosphate)29 July 2026The FDA approved Glycophos (sodium glycerophosphate), a drug from Fresenius Kabi Usa. Form: Solution, Intravenous. Application NDA220381.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)